JPRN-UMIN000003643招募中未知
Therapeutic efficacy and safety of chronotherapy of methotrexate in patients with rheumatic arthritis: double-blind randomized trial - Chronotherapy of MTX in RA patients
Department of Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama0 个研究点目标入组 70 人开始时间: 2010年6月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded from the study if any of the following criteria applied: (1) concurrent pregnancy, (2) the presence of serious complications in the heart, lung, kidney, etc., (3) perform of surgical operation for rheumatoid arthritis within a period of 6 months before administration (4) use of glucocorticoids(10.1 mg/day) within a period of one month before administration or (5) any other reason for which the investigator judged the patient to be unfit for study.
研究者
相似试验
招募中
不适用
Effect and Safety of Chronotherapy Compared to Conventional therapy in the Elderly Patients with Nocturnal HypertensioDiseases of the circulatory systemKCT0007518Chungbuk National University Hospital300
已完成
不适用
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)Resectable pancreatic cancerJPRN-UMIN000027441Osaka University10
未知
不适用
A study and Exploratory Clinical trial on chronological changes of the Iomazenil SPECT in coping with Higher brain dysfunction after cerebral traumaHigher brain dysfunction following traumatic brain injuryJPRN-UMIN000021732Hokkaido University Hospital20
已完成
4 期
Effects and safety of three-weeks supplementation with Cera-Q (a silkworm cocoon extract) on memory and cognition in healthy adults.ACTRN12618001682235Bio and Gene73
招募中
2 期
Efficacy and safety study of a therapeutic regimen using Tamibarotene (Am80) and arsenic trioxide (ATO) in combination with Gemtuzumab Ozogamicin (GO) as a post-remission therapy for relapsed acute promyelocytic leukemia (APL)Relapsed acute promyelocytic leukemiaRelapsed acure promyelocytic leukemia, Tamibarotene, Arsenic trioxide, Gemtuzumab ozogamicinJPRN-jRCTs041190101Kiguchi Toru39